Ambio significantly reduces the cost of remote patient monitoring.
Diabetes and hypertension are two of the most prevalent and costly chronic conditions. Studies have shown that Remote Patient Monitoring (RPM), especially in conjunction with telephonic patient support, reduces hospitalization costs. Ambio significantly lowers the intervention breakeven point for RPM.
Historically the cost of RPM technology was only justified for patients most at risk of expensive hospitalizations. Ambio significantly bends the cost curve for remote patient monitoring so that it is also beneficial for moderate risk hypertensive and diabetic patients. To illustrate, two recent studies of RPM with telephonic patient support showed positive outcomes at a reported cost of $1,395 and $3,600 PPPY respectively. In the Blood Pressure study, substituting Ambio and using the same provider support time would reduce the intervention cost by 50% - from $1395 PPPY to $695 PPPY. In the Diabetes study, substituting Ambio and realizing some provider support labor efficiencies would reduce the intervention cost from $3600 PPPT to $1800 PPPY.
| Study | Study Outcomes | Study Intervention Cost | Pro-forma cost using Ambio |
|---|---|---|---|
| Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control, Karen L. Margolis, JAMA. 2013; 310(1):46-56 | Compared with the usual care group, Systolic BP decreased more from baseline among patients in the telemonitoring intervention group at 6 months (−10.7 mm Hg), at 12 months (−9.7 mm Hg), and at 18 months (−6.6 mm Hg). |
$1395 PPPY $850 PPPY for remote patient monitoring technology plus $545 PPPY for provider time |
$695 PPPY $150 PPPY for remote patient monitoring technology plus $545 PPPY for provider time |
| Telehealth Program for Medicaid Patients with Type 2 Diabetes Lowers Hemoglobin A1c Kelly D. Stamp, Journal of Managed Care Medicine, Vol. 15, No. 4 | T2DM Medicaid patients showed a clinically and statistically significant improvement in mean glycosylated hemoglobin (HbA1c) of -1.8 percent Note: A 1 percent reduction of HbA1c was associated with a 35 percent reduction in macro vascular endpoints |
$3600 PPPY |
$1800 PPPYNote: Lower remote patient monitoring technology cost and provider support efficiencies |
Get in touch with us to schedule a free demo!
Schedule a demo
"FDA clears Ambio wireless health monitoring system"
eWeek's CES "10 Health and Fitness Tools To Track Exercise, Chronic Conditions."
2013 Medical Design Excellence Award Finalist
2013 “Caregiver Friendly” Award Winner
